CMV INFECTION
Clinical trials for CMV INFECTION explained in plain language.
Never miss a new study
Get alerted when new CMV INFECTION trials appear
Sign up with your email to follow new studies for CMV INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New score may cut Post-Transplant virus risk
Disease control Not yet recruitingThis study tests a new scoring system that uses the body's immune recovery to decide how long patients should take antiviral medicine after a stem cell transplant. The goal is to prevent a common virus called CMV from coming back when the medicine stops. About 1,100 transplant re…
Matched conditions: CMV INFECTION
Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 17, 2026 10:23 UTC
-
New trial tests antiviral eye drops and pills to stop recurring eye infection
Disease control Not yet recruitingThis study tests two antiviral treatments—oral valganciclovir and ganciclovir eye drops—against placebo in adults with CMV anterior uveitis, an eye infection causing inflammation. The goal is to see which approach reduces the virus faster and prevents the infection from coming ba…
Matched conditions: CMV INFECTION
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Transplant patients may get smarter CMV care
Disease control Not yet recruitingThis study looks at whether adjusting the dose of anti-rejection drugs can help organ transplant patients better fight off a common virus called CMV. About 100 adults who have had a kidney, liver, heart, lung, or pancreas transplant and have a CMV infection will take part. The go…
Matched conditions: CMV INFECTION
Phase: PHASE4 • Sponsor: Oriol Manuel • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
New drug may offer better protection against virus after kidney transplant
Prevention Not yet recruitingThis study tests if letermovir can prevent cytomegalovirus (CMV) infection in kidney transplant patients as well as the standard drug valganciclovir. About 300 CMV-positive adults will receive letermovir after transplant, and their results will be compared to past patients who to…
Matched conditions: CMV INFECTION
Phase: PHASE4 • Sponsor: Elisabeth Kincaide • Aim: Prevention
Last updated May 17, 2026 10:09 UTC